Abstract
Pericarditis, the most common disease of the pericardium, may be isolated or a manifestation of a systemic disease. The etiology of pericarditis is varied and includes infectious (especially viral and tuberculosis) and noninfectious causes (autoimmune and autoinflammatory diseases, pericardial injury syndromes, and cancer [especially lung cancer, breast cancer, and lymphomas]). Most cases remain idiopathic with a conventional diagnostic evaluation. A targeted etiologic search should be directed to the most common cause on the basis of the patient’s clinical background, epidemiologic issues, specific presentations, and high-risk features associated with specific etiologies or complications (fever higher than 38°C, subacute onset, large pericardial effusion, cardiac tamponade, lack of response to NSAIDs). The management of pericardial diseases is largely empiric because of the relative lack of randomized trials. NSAIDs are the mainstay of empiric anti-inflammatory therapy, with the possible addition of colchicine to prevent recurrences.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008;94:498–501. This was a contemporary prospective study with a comparison of clinical features and prognosis of simple acute pericarditis and myopericarditis.
• Imazio M, Brucato A, Trinchero R, Adler Y. Diagnosis and management of pericardial diseases. Nat Rev Cardiol. 2009;6:743–51. This is an updated review on the diagnosis and management of pericardial diseases.
•• Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010;121:916–28. This is a contemporary review of the main controversies surrounding the management of pericardial diseases.
• Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown). 2009;10:217–30. This is a comprehensive review on the etiology and diagnosis of pericarditis.
Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010;11:928–35.
Castagna L, Furst S, El Cheikh J, et al. Parvovirus B19 as an etiological agent of acute pleuro-pericarditis. Bone Marrow Transplant. 2010 Apr 26. (Epub ahead of print).
Imazio M, Spodick DH, Brucato A, et al. Diagnostic issues in the clinical management of pericarditis. Int J Clin Pract. 2010;64:1384–92.
Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med. 2009;6:120–7.
Mookadam F, Moustafa SE, Sun Y, et al. Infectious pericarditis: an experience spanning a decade. Acta Cardiol. 2009;64:297–302.
Inkster T, Khanna N, Diggle M, Sonecki P. Diagnosis of pneumococcal pericarditis using antigen testing and polymerase chain reaction. Scand J Infect Dis. 2010;42:791–3.
Levy PY, Gouriet F, Habib G, et al. Diagnosis of Coxiella burnetii pericarditis by using a systematic prescription kit in cases of pericardial effusion: an 8-year experience. Clin Microbiol Infect. 2009;15 Suppl 2:173–5.
Abu-Hijleh M, Evans S, Aswad B. Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature. Lung. 2010;188:505–10.
Cantarini L, Lucherini OM, Cimaz R, et al. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22:1051–8.
Okutur K, Seber S, Oztekin E, et al. Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. Med Sci Monit. 2008;14:CS139–41.
Cantarini L, Lucherini OM, Baldari CT, et al. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol. 2010;28:405–7.
Erlich JF, Paz Z. Postpericardial injury syndrome: an autoimmune phenomenon. Clin Rev Allergy Immunol. 2010;38:156–8.
Imazio M, Negro A, Belli R, et al. Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2009;103:1525–9.
• Imazio M, Trinchero R, Brucato A, et al. COPPS Investigators. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749–54. This is the largest double-blind, randomized trial supporting the efficacy and safety of colchicine for the primary prevention of the PPS.
Hamza A, Tunick PA, Kronzon I. Echocardiographic manifestations of complications of radiation therapy. Echocardiography. 2009;26:724–8.
•• Brucato A, Maestroni S, Cumetti D, et al. Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev. 2008;8:44–7. This is a contemporary updated review on the pathogenesis of recurrent pericarditis.
Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol. 2009;136:289–93.
• Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96:779–84. This was a contemporary prospective study investigating the pathogenesis of IRAP.
• Cantarini L, Imazio M, Brizi MG, et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol. 2010;(Epub ahead of print). This is an updated review on the role of autoimmunity and autoinflammatory conditions in the pathogenesis of recurrent pericarditis.
•• Khandaker MH, Espinosa RE, Nishimura RA, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85(6):572–93. This is an article on the Mayo Clinic experience and a review of the diagnosis and management of pericardial diseases.
• Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011 Mar 15;123(10):1092–7 (Epub 2011 Feb 28). This was the first prospective cohort study on time course of C-reactive protein normalization in acute pericarditis and its therapeutic implications.
Punja M, Mark DG, McCoy JV, et al. Electrocardiographic manifestations of cardiac infectious-inflammatory disorders. Am J Emerg Med. 2010;28:364–77.
Calabrese F, Carturan E, Thiene G. Cardiac infections: focus on molecular diagnosis. Cardiovasc Pathol. 2010;19:171–82.
Kim SH, Song JM, Jung IH, et al. Initial echocardiographic characteristics of pericardial effusion determine the pericardial complications. Int J Cardiol. 2009;136:151–5.
Hernandez CM, Singh P, Hage FG, et al. Live/real time three-dimensional transthoracic echocardiographic assessment of pericardial disease. Echocardiography. 2009;26:1250–63.
Rajiah P, Kanne JP. Computed tomography of the pericardium and pericardial disease. J Cardiovasc Comput Tomogr. 2010;4:3–18.
Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson. 2009;11:11–4.
Napolitano G, Pressacco J, Paquet E. Imaging features of constrictive pericarditis: beyond pericardial thickening. Can Assoc Radiol J. 2009;60:40–6.
Schwefer M, Aschenbach R, Heidemann J, et al. Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur J Cardiothorac Surg. 2009;36:502–10.
• Yared K, Baggish AL, Picard MH, et al. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging. 2010;3:650–60. This is an updated review on multimodality imaging of pericardial diseases.
• Verhaert D, Gabriel RS, Johnston D, et al. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging. 2010;3:333–43. This is a contemporary review on integrated imaging for pericardial diseases.
Azam S, Hoit BD. Treatment of pericardial disease. Cardiovasc Ther. 2010 (Epub ahead of print).
• Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown). 2010;11:712–22. This and the reference that immediately follows represent an updated review on the medical therapy for pericardial diseases in two parts.
Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med (Hagerstown). 2010;11:785–94.
Cornily JC, Pennec PY, Castellant P, et al. Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology. 2008;111:197–201.
• Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–71. This was the first comparative study on the use of high versus low doses of corticosteroids for recurrent pericarditis.
Farand P, Bonenfant F, Belley-Côté EP, Tzouannis N. Acute and recurring pericarditis: more colchicine, less corticosteroids. World J Cardiol. 2010;2:403–7.
• Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160:662–70. This is the first meta-analysis on medical therapies for acute and recurrent pericarditis.
Frasiolas JA, Cahoon WD. Intrapericardial triamcinolone administration for autoreactive pericarditis. Ann Pharmacother. 2010;44:1641–6.
• Imazio M, Brucato A, Trinchero R, et al. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30:532–9. This is an updated and comprehensive review on the use of colchicine in the medical treatment of pericarditis.
Imazio M, Trinchero R, Adler Y. Colchicine for the treatment of pericarditis. Future Cardiol. 2008;4:599–607.
Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum. 2009;38:411–9.
Cocco G, Chu DC, Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med. 2010;21:503–8.
• Lestuzzi C, Bearz A, Lafaras C, et al. Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer. 2010;(Epub ahead of print). This was the first comparative study on different treatment strategies for neoplastic pericarditis in lung cancer patients.
• Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol. 2008;127:17–26. This is an updated contemporary review on myopericarditis with a focus on practical management.
Machado S, Roubille F, Gahide G, et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris). 2010;59:1–7.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imazio, M. Pericarditis: Pathophysiology, Diagnosis, and Management. Curr Infect Dis Rep 13, 308–316 (2011). https://doi.org/10.1007/s11908-011-0189-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-011-0189-5